リトゥキシマブ療法に関連する輸液反応の危険因子
Takahiro Amemiya1,2, Hiroshi Suzuki2
1Faculty of Pharmaceutical Sciences, Teikyo Heisei University, Tokyo, Japan.
Cancer diagnosis & prognosis
|September 3, 2025
まとめ
リトゥキシマブ治療前のC反応性タンパク質 (CRP) の上昇は,注射反応のリスクを大幅に増加させる. リトゥキシマブ治療の前に,高いCRPレベルを有する患者を注意深くモニタリングすることが推奨されます.
科学分野:
- 免疫学
- 薬理学について
- 臨床医学
背景:
- リトゥキシマブは,様々な病気の治療用抗体として広く使用されています.
- リトゥキシマブに関連した輸液反応 (IR) は,一般的な臨床的課題です.
- IRの治療前の危険因子を特定することは,患者の安全にとって極めて重要です.
研究 の 目的:
- リトゥキシマブによる輸液反応の治療前の危険因子を特定する.
- IRとの関連を決定するために,患者からの遡及データを分析する.
主な方法:
- リトゥキシマブで治療された患者の医療記録を遡って分析した.
- IRを経験した患者と,IRを経験しなかった患者のデータを比較する.
主要な成果:
- リトゥキシマブ投与前のC反応性タンパク質 (CRP) の値上昇は,IRの発生と有意に関連していた.
- CRPが上昇したIRの確率比は2. 591 (95%CI: 1. 160- 5. 791, p=0. 020) であった.
結論:
- 治療前のCRP濃度の上昇は,リトキシマブ誘発性IRの重要な危険因子である.
- リトゥキシマブ治療の前にCRPが上昇した患者は,注意深くモニタリングする必要があります.
- この発見は,リトキシマブ治療プロトコルと患者の管理を最適化するのに役立ちます.
さらに関連する動画
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.4K
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
17.8K
関連する概念動画
01:27Allergic Drug Reactions
972
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
972
02:06Allergic Reactions
28.5K
Overview
28.5K
01:20Rheumatic Heart Disease IV: Nursing Management
36
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
36
01:29Pulmonary Tuberculosis I
321
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
321
02:45Blood Transfusion and Agglutination
11.2K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.2K
01:23Rheumatic Heart Disease I: Introduction
38
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
38